Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Hooper

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|June 28, 2005
Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IVJohn H Tran, George A Jacoby, David C Hooper
Microbiology Spectrum|December 10, 2024
Characterization of YdgH: a mediator of beta-lactam susceptibility in EnterobacteralesJacob E Lazarus, Matthew K Waldor, David C Hooper
Infectious Disease Clinics of North America|May 31, 2022
Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care SettingsMarisa L Winkler, David C Hooper, Erica S Shenoy
Antimicrobial Agents and Chemotherapy|February 24, 2006
NorC, a new efflux pump regulated by MgrA of Staphylococcus aureusQue Chi Truong-Bolduc, Jacob Strahilevitz, David C Hooper
Antimicrobial Agents and Chemotherapy|August 5, 2015
Protective effect of Qnr on agents other than quinolones that target DNA gyraseGeorge A Jacoby, Marian A Corcoran, David C Hooper
The Journal of Antimicrobial Chemotherapy|April 15, 2014
QnrS1 structure-activity relationshipsMaría M Tavío, George A Jacoby, David C Hooper
Antimicrobial Agents and Chemotherapy|March 30, 2021
Analyzing Possible Native Functions of the Quinolone Resistance Gene <i>qnr</i> in Vibrio vulnificusMaría Luisa Gil-Marqués, George A Jacoby, David C Hooper
Clinical Microbiology Reviews|October 14, 2009
Plasmid-mediated quinolone resistance: a multifaceted threatJacob Strahilevitz, George A Jacoby, David C Hooper, et al.
Journal of Bacteriology|October 9, 2012
Staphylococcus aureus NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivoYanpeng Ding, Yingmei Fu, Jean C Lee, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureusDilek Ince, Xiamei Zhang, L Christine Silver, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|June 28, 2005
Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IVJohn H Tran, George A Jacoby, David C Hooper
Microbiology Spectrum|December 10, 2024
Characterization of YdgH: a mediator of beta-lactam susceptibility in EnterobacteralesJacob E Lazarus, Matthew K Waldor, David C Hooper
Infectious Disease Clinics of North America|May 31, 2022
Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care SettingsMarisa L Winkler, David C Hooper, Erica S Shenoy
Antimicrobial Agents and Chemotherapy|February 24, 2006
NorC, a new efflux pump regulated by MgrA of Staphylococcus aureusQue Chi Truong-Bolduc, Jacob Strahilevitz, David C Hooper
Antimicrobial Agents and Chemotherapy|August 5, 2015
Protective effect of Qnr on agents other than quinolones that target DNA gyraseGeorge A Jacoby, Marian A Corcoran, David C Hooper
The Journal of Antimicrobial Chemotherapy|April 15, 2014
QnrS1 structure-activity relationshipsMaría M Tavío, George A Jacoby, David C Hooper
Antimicrobial Agents and Chemotherapy|March 30, 2021
Analyzing Possible Native Functions of the Quinolone Resistance Gene <i>qnr</i> in Vibrio vulnificusMaría Luisa Gil-Marqués, George A Jacoby, David C Hooper
Clinical Microbiology Reviews|October 14, 2009
Plasmid-mediated quinolone resistance: a multifaceted threatJacob Strahilevitz, George A Jacoby, David C Hooper, et al.
Journal of Bacteriology|October 9, 2012
Staphylococcus aureus NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivoYanpeng Ding, Yingmei Fu, Jean C Lee, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureusDilek Ince, Xiamei Zhang, L Christine Silver, et al.
Pageof 18